Category Archives: HIV/AIDS

Treat all policies saw increased access, uptake of antiretroviral treatment among teenagers who had lived with the virus from infancy

By on .

Well into the era of effective treatment for HIV, a question contributed to a lag in access to the life-saving antiretroviral drugs in resource limited countries: If everyone was eligible for the medicine, would those who need it most urgently be crowded out? Just the opposite, a study tracking data on antiretroviral treatment initiation among […]

More than 20 years after the advent of effective ART, hospitalizations, readmissions for HIV-related illnesses in southern U.S. highlight inequities

By on .

With the discovery of combination antiretroviral treatment in 1996 came a remarkable turning point in the United States epidemic: Not only were people living with HIV living longer, they were staying out of the hospital, with admissions of people whose immune systems had been devastated by the virus dropping steadily, and lengths of stay for […]

IDWeek: Ending HIV as an epidemic will demand innovation, inclusion, an expanded workforce — and funding

By on .

As the federal Ending the HIV epidemic takes form, experts talk details, challenges: “How do we get there from here?” WASHINGTON, DC – Nearly four decades into an epidemic that has taken the lives more than 700,000 people in America, still close to 40,000 people in this country are diagnosed with HIV here each year. […]

When viral suppression didn’t last, lowering barriers to HIV treatment and care made a difference

By on .

The goals of controlling HIV sound like a straight forward series of three consecutive steps, one following another, when discussed in global and domestic epidemic-ending plans. If 90 percent of all people living with the virus knew it, 90 percent of them access antiretroviral treatment, and 90 percent of those on treatment — that is […]

IAS 2019: Collapse of Venezuela’s health infrastructure dismantles HIV response

By on .

MEXICO CITY – A decade ago, Venezuela had one of the most progressive responses to its HIV epidemic in the world. In the 1990s the country’s Supreme Court mandated that the government provide lifesaving antiretroviral therapy, catalyzing a national HIV program which provided comprehensive care to everyone who qualified. Now, after more than five years […]

IAS 2019: Scientist highlights the weight of the smallest organism in HIV risk

By on .

MEXICO CITY – When you think of factors associated with increased risks of acquiring HIV, big pictures of marginalization, discrimination, geographic location, economic inequities and gender inequality might come to mind. With two maps here on Tuesday, a scientist zeroed in on a factor that, while literally microscopic, can also make a great difference: bacteria. On […]

IAS 2019: While plans for HIV control innovations accelerate, community input remains an afterthought

By on .

MEXICO CITY – “What HIV has pointed out is that building it does not make them come,” Ambassador Dr. Deborah Birx noted at an opening night press event that highlighted persisting gaps in HIV testing, treatment, prevention access across the globe. When services don’t reach clients and communities, she said, people offering them have to […]

IAS 2019: While dispelling concerns of DPM HIV risk, ECHO study yields data on STIs, PrEP interest, pregnancy rates

By on .

MEXICO CITY – Women using Depo Provera as a long acting, injectable hormonal contraceptive showed lower rates of sexually transmitted infection that include chlamydia and gonorrhea, during a study undertook with the primary aim of assessing whether the drug raised risks of HIV infection. This is one in several findings released Monday from the Evaluation of […]

IAS 2019: Data shows indigenous, nonbinary populations among those missed by HIV epidemic ending efforts

By on .

MEXICO CITY – Indigenous communities in the Americas are largely being left out of efforts to achieve UNAIDS’ global HIV elimination targets of 90 percent of people knowing their HIV status by 2020, 90 percent of people diagnosed with HIV accessing lifesaving antiretroviral therapy, and 90 percent of people on treatment achieving viral suppression, indigenous leaders […]

IAS 2019: With new data, WHO updates DTG guidelines including women in strong, preferred recommendation

By on .

MEXICO CITY – Responding to expanded data gathered in Botswana and Brazil, and to input from communities of women living with HIV, the World Health Organization announced updated guidelines for the use of dolutegravir, restoring the agency’s recommendation that the antiretroviral medicine with fewer side effects, lower resistance, and quicker viral suppression than alternatives is […]